Name: UMIN ID:
Unique ID issued by UMIN | UMIN000019876 |
---|---|
Receipt number | R000022954 |
Scientific Title | A phase I/II study for the safety and efficacy of Panitumumab in combination with TAS-102 for patients with RAS wild-type metastatic colorectal cancer refractory to standard chemotherapy |
Date of disclosure of the study information | 2015/11/20 |
Last modified on | 2019/05/23 15:06:26 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/11/20 16:51:50 | ||
2 | Update | 2015/12/03 18:02:43 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 Study ID_2 Org. issuing International ID_2 Org. issuing International ID_2 |
|
3 | Update | 2015/12/03 18:03:17 | Recruitment status |
|
4 | Update | 2015/12/03 18:05:41 | Acronym Acronym |
|
5 | Update | 2015/12/03 18:07:50 | Acronym Acronym |
|
6 | Update | 2015/12/03 18:11:40 | Primary outcomes Primary outcomes Key secondary outcomes |
|
7 | Update | 2016/09/12 09:06:05 | Name of primary person or sponsor Organization |
|
8 | Update | 2017/04/07 12:54:07 | Recruitment status |
|
9 | Update | 2017/04/07 13:04:42 | Organization Organization Division name Division name Address Address |
|
10 | Update | 2017/11/21 19:06:31 | Address |
|
11 | Update | 2019/05/23 15:06:26 | Recruitment status Date of IRB Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |